Skip to search formSkip to main contentSkip to account menu

Xanthinol Niacinate

Known as: Xantinol Nicotinate, 3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1), Nicotinate, Xanthinol 
A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
The effect of food on absorption of d,1-alpha-tocopheryl nicotinate was studied in cross-over studies with eight beagle dogs and… 
1979
1979
SummaryThe effect of nicotinic acid and several derivatives on the nocturnal level of free fatty acids was studied in 12 healthy… 
1979
1979
The therapeutic role of xanthinol nicotinate, with its potent action on the peripheral circulation, in promoting healing of leg… 
1977
1977
A double-blind multiclinic trial compared the efficacies of pyridinolcarba mate and inositol niacinate in the patients with the… 
1977
1977
The effects of twelve substances on local cerebral blood flow (LCBF) were studied in the normocapnic and hypercapnic conscious… 
1977
1977
Treatment of 24 male patients with 3 g/day of xanthinol nicotinate did not change the in vitro measurements of ADP-induced… 
1976
1974
1974
W. B. III. Effect of prostaglandin E1 on electrolyte transport in rabbit ileal mucosa [abstract]. J. Clin. Invest. 49:2a, 1970… 
1971
1971
When incubated with 14C-nicotinic acid and phosphorylribose-1-pyrophosphate, human platelet lysate incorporates radioactivity…